53 related articles for article (PubMed ID: 36428565)
1. Use of dose-volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres.
Coskun N; Kartal MO; Kartal AS; Cayhan V; Ozdemir M; Canyigit M; Ozdemir E
Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38647875
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic Changes after Yttrium-90 Radioembolization of Colorectal Liver Metastases: A Pilot Feasibility Study.
Kitsel Y; Vakiani E; Kirov A; Zirakchian Zadeh M; Kunin H; Petre EN; Crane CH; Romesser P; Sotirchos VS; Sofocleous CT
J Vasc Interv Radiol; 2024 Apr; ():. PubMed ID: 38670528
[TBL] [Abstract][Full Text] [Related]
3. FDG PET/CT Imaging of Sarcomatoid Hepatocellular Carcinomaļ¼A case report.
Chen Z; Wang H; Yu X
Asian J Surg; 2024 Apr; ():. PubMed ID: 38664188
[No Abstract] [Full Text] [Related]
4. The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE).
Quartuccio N; Ialuna S; Scalisi D; D'Amato F; Barcellona MR; Bavetta MG; Fusco G; Bronte E; Musso E; Bronte F; Picciotto V; Carroccio A; Verderame F; Malizia G; Cistaro A; La Gattuta F; Moreci AM
Curr Oncol; 2024 Mar; 31(3):1504-1514. PubMed ID: 38534947
[TBL] [Abstract][Full Text] [Related]
5. Bench to Bedside Development of [
Challapalli A; Barwick TD; Dubash SR; Inglese M; Grech-Sollars M; Kozlowski K; Tam H; Patel NH; Winkler M; Flohr P; Saleem A; Bahl A; Falconer A; De Bono JS; Aboagye EO; Mangar S
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138508
[TBL] [Abstract][Full Text] [Related]
6. Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma.
Nyakale N; Filippi L; Aldous C; Sathekge M
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046636
[TBL] [Abstract][Full Text] [Related]
7. The application of
Yao Y; Civelek AC; Li XF
Quant Imaging Med Surg; 2023 Sep; 13(9):6268-6279. PubMed ID: 37711813
[TBL] [Abstract][Full Text] [Related]
8.
Hemrom A; Tupalli A; Alavi A; Kumar R
PET Clin; 2022 Jul; 17(3):415-430. PubMed ID: 35717100
[TBL] [Abstract][Full Text] [Related]
9. PET/CT with
Filippi L; Bagni O; Notarianni E; Saltarelli A; Ambrogi C; Schillaci O
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428565
[TBL] [Abstract][Full Text] [Related]
10. Utility of Early Posttreatment PET/CT Evaluation Using FDG or
Reizine E; Chalaye J; Mule S; Regnault H; Perrin C; Calderaro J; Laurent A; Amaddeo G; Kobeiter H; Tacher V; Itti E; Luciani A
AJR Am J Roentgenol; 2022 Feb; 218(2):359-369. PubMed ID: 34494448
[No Abstract] [Full Text] [Related]
11. Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization.
Hwang SH; Hong HS; Kim D; Kim GM; Lee HW; Lee M; Kim DY; Park MA; Yun M
Clin Nucl Med; 2022 Jun; 47(6):e437-e443. PubMed ID: 35384891
[TBL] [Abstract][Full Text] [Related]
12. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
[TBL] [Abstract][Full Text] [Related]
13. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.
Talbot JN; Gutman F; Fartoux L; Grange JD; Ganne N; Kerrou K; Grahek D; Montravers F; Poupon R; Rosmorduc O
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1285-9. PubMed ID: 16802155
[TBL] [Abstract][Full Text] [Related]
14. Role of
Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
[TBL] [Abstract][Full Text] [Related]
15. Trans-arterial Radioembolization Dosimetry in 2022.
Garin E; Guiu B; Edeline J; Rolland Y; Palard X
Cardiovasc Intervent Radiol; 2022 Nov; 45(11):1608-1621. PubMed ID: 35982334
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
